Expanded haemodialysis: news from the field
| Autor: | Laurent Juillard, Nans Florens |
|---|---|
| Přispěvatelé: | Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National de la Recherche Agronomique (INRA), Hospices Civils de Lyon (HCL), Baxter Healthcare Corporation, ProdInra, Migration, Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM) |
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
030232 urology & nephrology Tissue membrane Reviews Hemodiafiltration 030204 cardiovascular system & hematology [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology Rhabdomyolysis 03 medical and health sciences Dialysis solutions 0302 clinical medicine Renal Dialysis Dialysis Solutions Restless Legs Syndrome haemodialysis membrane Medicine Humans Adverse effect Intensive care medicine Transplantation business.industry chronic haemodialysis medium cut-off Membranes Artificial [SDV.MHEP.UN] Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology 3. Good health Molecular Weight Nephrology HDx business Multiple Myeloma uraemic toxins |
| Zdroj: | Nephrology Dialysis Transplantation Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2018, 33, pp.48-52. ⟨10.1093/ndt/gfy203⟩ Nephrology Dialysis Transplantation, 2018, 33, pp.48-52. ⟨10.1093/ndt/gfy203⟩ |
| ISSN: | 0931-0509 1460-2385 |
| DOI: | 10.1093/ndt/gfy203⟩ |
| Popis: | International audience; Expanded haemodialysis (HDx) has emerged as a promising solution to improve haemodialysis effectiveness. A medium cutoff membrane allows the removal of a wider range of uraemic toxins. However, little is known about the potential interesting applications of HDx therapy. Feedback from the first routine use of HDx therapy under real-life conditions in European facilities was excellent for priming and rinse back. There was no adverse event after 5191 HDx treatments. Patients suffering from itching, restless legs syndrome, persistent asthenia or malnourishment could benefit from HDx therapy. Moreover, we discuss here the promising applications in which HDx could be valuable (myeloma, rhabdomyolysis or cardiovascular diseases). This enthusiastic message is mitigated by reminding why and how prudence should be taken in the design of future HDx studies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|